# Bioequivalence Study of Ribavirin in Healthy Adult Subjects Under Fed Condition

> **NCT05532306** · PHASE1 · COMPLETED · sponsor: **Future University in Egypt** · enrollment: 36 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** Ribavirin 400 mg film coated tablet (1*400mg)
- **DRUG:** Copegus® 200 mg film coated tablet (2*200mg)

## Key facts

- **NCT ID:** NCT05532306
- **Lead sponsor:** Future University in Egypt
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-11
- **Primary completion:** 2020-11-23
- **Final completion:** 2020-11-23
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2022-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05532306

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05532306, "Bioequivalence Study of Ribavirin in Healthy Adult Subjects Under Fed Condition". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05532306. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*